COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Developments on March 1, 2018
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
Tower One Continues to Build and Receive Additional Search Rings
08/02/2018
VANCOUVER, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces that tower demand in Argentina has remained [...]
Cellectar Biosciences to Present at the 2018 BIO CEO & Investor Conference
08/02/2018
MADISON, Wis., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]
Momenta Pharmaceuticals to Webcast Presentation at the LEERINK Partners 7th Annual Global Healthcare Conference
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it [...]
Genocea to Host Fourth Quarter and Year End 2017 Financial Results Conference Call & Webcast on February 15, 2018 at 9 a.m. ET
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that it will host a conference call and [...]
Zogenix to Participate in Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]
Opiant Pharmaceuticals to Record Approximately $11.7 Million in Royalty and Milestone Payments Related to 2017 Sales of NARCAN® Nasal Spray for Opioid Overdose
08/02/2018
SANTA MONICA, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced [...]
Provant Health to Provide Biometric Screenings at American Heart Association’s Go Red for Women Event
08/02/2018
OLATHE, Kan., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. d/b/a Provant Health (OTCQX:HPHW), the largest publicly traded, pure-play well-being leader in workplace population health and clinical research [...]
Alder BioPharmaceuticals® to Present at Two Upcoming February Investor Conferences
08/02/2018
BOTHELL, Wash., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Rexahn Pharmaceuticals Announces Collaboration with Zhejiang Haichang Biotechnology Co., Ltd. for the Development of RX-0201 (Archexin®) for the treatment of Hepatocellular Carcinoma
08/02/2018
Haichang to fund development through completion of Phase IIa Proof-of-Concept Clinical Trial Clinical trials will be designed to meet both the US and China FDA requirements ROCKVILLE, Md., Feb. 08, 2018 (GLOBE NEWSWIRE [...]
Radius Health to Present at Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
WALTHAM, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative [...]
Emerald Health Therapeutics Announces $18 Million Prospectus Sale; Concurrent Secondary Sale
08/02/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VICTORIA, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) ("Emerald" [...]
HempAmericana Teams Up With High Times Magazine as CBD Oil Production Nears
08/02/2018
NEW YORK, Feb. 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--HempAmericana, Inc. (OTC:HMPQ) is thrilled to announce that they are teaming up with the iconic cannabis media platform for coming coverage in the legendary [...]
Actinium Appoints Anil Kapur as Chief Commercial Officer to Build Critical Commercial & Launch Capabilities Focused on Myeloablation
08/02/2018
- Mr. Kapur joins Actinium with more than two decades of biopharmaceutical commercial experience at Johnson & Johnson, BAXALTA and Bristol-Myers Squibb - Global leader with deep expertise in Oncology Marketing [...]
Adverum Biotechnologies Announces Pricing of $60 Million Public Offering of Common Stock
08/02/2018
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Nextech Keeps Focus on Care at the American Academy of Dermatology Annual Meeting
08/02/2018
TAMPA, Fla., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, showcases NexCloud, its exclusively dermatology-engineered cloud [...]
Capital Senior Living Corporation Announces Release Date for Fourth Quarter and Full Year 2017 Financial Results
08/02/2018
DALLAS, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE: CSU ) will host a conference call with senior management to discuss the Company’s fourth quarter and full year 2017 financial results. [...]
Arch Biopartners Arranges Convertible Note Financing
08/02/2018
TORONTO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture:ARCH) (OTCBB: ACHFF ), announced it has arranged a non-brokered, unsecured convertible note (“Note”) financing for [...]
Wave Life Sciences to Participate in Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE ), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined [...]

Pages